Decision Making for Cancer Clinical Trial Participation: A Systematic Review
- 1 November 2010
- journal article
- review article
- Published by Oncology Nursing Society (ONS) in Oncology Nursing Forum
- Vol. 37 (6) , E387-E399
Abstract
To describe what is known about the factors that influence cancer clinical trial decision making. PubMed database and reference lists of identified articles. Variations in research design and methods, including sample characteristics, instrumentation, time between decision made and measurement of decision making, and response rates, have effects on what is known about decision making for cancer clinical trial participation. Communication, whether in the form of education about a cancer clinical trial or as a personal invitation to join, is an important factor influencing decision making. Personal and system factors influence the outcomes of decision making for cancer clinical trials. The process of decision making for cancer clinical trials is understudied. Nevertheless, the currently available cancer clinical trial decision-making literature suggests a multitude of factors that influence the outcomes of the decision to accept or decline clinical trial participation, as well as the psychosocial consequences of decisional regret, pressures, and satisfaction. The decision-making process of cancer clinical trials is a fertile area for research and, subsequently, evidence-based interventions. Oncology nurses are in a position to facilitate the process and to relieve the pressures patients perceive regarding decision making for cancer clinical trials that will benefit individuals and, ultimately, society.Keywords
This publication has 41 references indexed in Scilit:
- Participants in Phase 1 Oncology Research TrialsAre They Vulnerable?Archives of internal medicine (1960), 2008
- Barriers to recruiting underrepresented populations to cancer clinical trials: A systematic reviewCancer, 2007
- Barriers to Clinical Trial Participation as Perceived by Oncologists and PatientsJournal of the National Comprehensive Cancer Network, 2007
- Risks and benefits associated with novel phase 1 oncology trial designsCancer, 2007
- Influence of tumor type, disease status, and patient age on self-reported interest regarding participation in cancer clinical trialsCancer, 2006
- Understanding of an aggregate probability statement by patients who are offered participation in Phase I clinical trialsCancer, 2004
- Barriers to the participation of African‐American patients with cancer in clinical trialsCancer, 2003
- Clinical Trials: Are They a Good Buy?Journal of Clinical Oncology, 2001
- Impact of Quality of Life on Patient Expectations Regarding Phase I Clinical TrialsJournal of Clinical Oncology, 2000
- Representation of African-Americans, Hispanics, and Whites in National Cancer Institute Cancer Treatment TrialsJNCI: Journal of the National Cancer Institute, 1996